Nesvacumab Biosimilar - Research Grade,ichor.bio,ICH5010
Detects human Ang-2. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Nesvacumab.
Host
CHO cells
Reactivity
Human
Platform ID
BAB762900512
ichor.bio
Contact
Tel:
Fax:
Email:
Product Specifications
Scientific Background
Synonyms
Specifications
NameNesvacumab Biosimilar - Research Grade
Cat. No.ICH5010
Accession NumberO15123
HostCHO cells
IsotypeHuman IgG1
ReactivityHuman
Concentration5mg/ml
TargetAngiopoietin 2
Purity>95% by SDS-PAGE
Endotoxin Level≤ 1.0 EU/mg as determined by the LAL method
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only
Scientific Background
RUO nesvacumab is an experimental monoclonal antibody originally designed for the treatment of cancer. It targets the protein angiopoietin 2. As of May 2017, it is in Phase II clinical trials for the treatment of diabetic macular edema.
Synonyms
ANGPT2, ANG2
Category Paths
- Products>Primary Antibodies>Biosimilar Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.